Insider 10b5-1 Sales Reported (VICR)

Rhea-AI Filing Summary

Company insider reported multiple 10b5-1 sales of common stock. The filing lists a series of 10b5-1 open-market sales by Patrizio Vinciarelli executed through Morgan Stanley Smith Barney LLC on multiple dates, with example transactions including 03/04/2026: 50,000 shares, 03/19/2026: 50,000 shares, and 12/30/2025: 20,000 shares. Each line item in the filing shows the date, number of shares sold, and gross proceeds for that trade.

Insights

Corporate Governance Specialist

Multiple 10b5-1 sales are routine disclosures of planned insider liquidity.

These entries document scheduled sales executed under a 10b5-1 plan by Patrizio Vinciarelli through Morgan Stanley Smith Barney LLC, listing per-trade share counts and gross proceeds. The filing records each trade date and amount, which is standard for compliance reporting.

Because the transactions are labeled 10b5-1, they appear pre-arranged; the filing itself does not alter capital structure and does not provide additional company-operational information. Subsequent filings would show any material change to ownership if it occurs.

Securities Compliance Analyst

Form 144-style notice documents the mechanics and proceeds of individual sales.

The excerpt lists individual sale dates, share quantities, and gross proceeds for each trade (for example, 03/04/2026: 50,000 shares for $10,077,245.00). That level of per-trade detail supports traceability to reported broker executions.

These disclosures satisfy routine reporting obligations; they do not state any change to issuer capitalization or indicate proceeds usage. Review of future ownership filings would clarify any post-sale position changes.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5924	974734.96	33646426	03/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/1981	Founders Shares	Issuer			5924	11/10/1981	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/20/2026	44076	7928258.16
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/19/2026	50000	8969588.75
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/18/2026	50000	9809142.46
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/17/2026	50000	9532498.30
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/16/2026	50000	9233644.50
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/13/2026	50000	8542808.13
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/12/2026	50000	8372990.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/11/2026	50000	8870435.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/10/2026	50000	8862570.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/09/2026	50000	8212935.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/06/2026	50000	8314785.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/05/2026	50000	9341275.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/04/2026	50000	10077245.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	12/31/2025	1883	215336.30
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	12/30/2025	20000	2259535.98
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	12/29/2025	5917	657962.22
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	12/26/2025	20000	2202474.09
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	12/24/2025	12400	1349971.88

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VICR filing report about insider trades?

It reports multiple 10b5-1 open-market sales by an executive, listing dates, share counts, and gross proceeds. The filing enumerates each trade (for example, 03/04/2026: 50,000 shares) and the reported dollar proceeds for that individual sale.

Who executed the trades reported in the VICR notice?

The trades are reported as 10b5-1 sales for Patrizio Vinciarelli, executed through Morgan Stanley Smith Barney LLC. Each line shows the executing broker, trade date, number of shares sold, and gross proceeds for that transaction.

Do these filings change Vicr's share count or capital structure?

No direct capital-structure change is stated in the excerpt; the filing lists individual sales by an insider with per-trade proceeds. The notice documents transfers of existing shares rather than any issuance or change to authorized shares.

Are the sales listed as discretionary or pursuant to a 10b5-1 plan?

The sales are labeled as 10b5-1, indicating they were executed under a pre-arranged trading plan. The filing lists each planned-sale execution date and amount, consistent with scheduled plan transactions.